These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21412126)

  • 1. Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.
    Appay V; Fastenackels S; Katlama C; Ait-Mohand H; Schneider L; Guihot A; Keller M; Grubeck-Loebenstein B; Simon A; Lambotte O; Hunt PW; Deeks SG; Costagliola D; Autran B; Sauce D
    AIDS; 2011 Sep; 25(15):1813-22. PubMed ID: 21412126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus, aging, and HIV: a perfect storm.
    Barrett L; Fowke KR; Grant MD
    AIDS Rev; 2012; 14(3):159-67. PubMed ID: 22833059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART.
    Fernandez S; French MA; Price P
    Dis Markers; 2011; 31(6):337-42. PubMed ID: 22182806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.
    Gerna G; Piccinini G; Genini E; Percivalle E; Zavattoni M; Lilleri D; Testa L; Comolli G; Maserati R; Baldanti F; Maccario R; Monforte AD; Revello MG
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):320-31. PubMed ID: 11707667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

  • 6. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune resilience in HIV-infected individuals seronegative for cytomegalovirus.
    Barrett L; Stapleton SN; Fudge NJ; Grant MD
    AIDS; 2014 Sep; 28(14):2045-9. PubMed ID: 25265072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100 x 10(6) cells/l following combination antiretroviral therapy including protease inhibitors.
    Gilquin J; Piketty C; Thomas V; Gonzales-Canali G; Belec L; Kazatchkine MD
    AIDS; 1997 Nov; 11(13):1659-60. PubMed ID: 9365778
    [No Abstract]   [Full Text] [Related]  

  • 12. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy.
    Ariyanto IA; Estiasari R; Waters S; Wulandari EAT; Fernandez S; Lee S; Price P
    Viral Immunol; 2018; 31(6):472-479. PubMed ID: 29688840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
    Harari A; Rizzardi GP; Ellefsen K; Ciuffreda D; Champagne P; Bart PA; Kaufmann D; Telenti A; Sahli R; Tambussi G; Kaiser L; Lazzarin A; Perrin L; Pantaleo G
    Blood; 2002 Aug; 100(4):1381-7. PubMed ID: 12149221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication.
    Worrell S; Deayton J; Hayes P; Emery VC; Gotch F; Gazzard B; Larsson-Sciard EL
    HIV Med; 2001 Jan; 2(1):11-9. PubMed ID: 11737371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity of Cytomegalovirus-Specific CD8
    Heath JJ; Fudge NJ; Gallant ME; Grant MD
    Front Immunol; 2018; 9():201. PubMed ID: 29527205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.